NCT05101070 2026-03-18
aCCeleR8-001
Shionogi Inc.
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT06885281 2026-02-13
A Study of ZL-1310 in Participants With Selected Solid Tumors
Zai Lab (Hong Kong), Ltd.
Phase 1/2 Recruiting
NCT07265622 2025-12-29
First-in-human Study of 7MW4911 in Patients With Advanced Solid Tumors
Mabwell (Shanghai) Bioscience Co., Ltd.
Phase 1/2 Recruiting
NCT07105215 2025-11-26
A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC278 in the Treatment of Solid Tumors
RemeGen Co., Ltd.
Phase 1/2 Recruiting
NCT07055594 2025-11-06
NbTAST-01
Shine-On Biomedical Co., Ltd.
Phase 1/2 Recruiting
NCT07158918 2025-09-08
ABL103 in Combination With Pembrolizumab, With or Without Taxane in Advanced or Metastatic Solid Tumors
ABL Bio, Inc.
Phase 1/2 Recruiting
NCT04685226 2025-09-02
A Phase I/II Clinical Trial of ICP-723 in the Treatment of Advanced Solid Tumors
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1/2 Recruiting
NCT06764628 2025-01-22
A Study of SHR-4375 in Subjects With Solid Tumors
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Phase 1/2 Recruiting
NCT06233292 2024-06-14
A Study of ZG005 in Patients With Advanced Solid Tumors
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2 Recruiting